Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Oral Oncology | journal | 1.735 Q1 | 137 | 317 | 798 | 9755 | 3046 | 652 | 3.57 | 30.77 | 33.43 | |
52 | Lung Cancer | journal | 1.705 Q1 | 148 | 321 | 824 | 9700 | 3759 | 766 | 4.30 | 30.22 | 36.19 | |
53 | Oncology Reviews | journal | 1.703 Q1 | 31 | 24 | 36 | 1638 | 207 | 35 | 6.14 | 68.25 | 32.18 | |
54 | Carcinogenesis | journal | 1.661 Q2 | 223 | 161 | 385 | 7247 | 1683 | 373 | 4.45 | 45.01 | 37.72 | |
55 | Frontiers in Oncology | journal | 1.654 Q2 | 136 | 1409 | 1235 | 84265 | 5880 | 1168 | 4.88 | 59.80 | 41.57 | |
56 | Genes Chromosomes and Cancer | journal | 1.639 Q2 | 130 | 100 | 245 | 6287 | 869 | 239 | 3.65 | 62.87 | 47.05 | |
57 | American Journal of Blood Research | journal | 1.590 Q2 | 6 | 0 | 1 | 0 | 4 | 1 | 0.00 | 0.00 | 0.00 | |
58 | American Journal of Cancer Research (discontinued) | journal | 1.562 Q2 | 64 | 0 | 423 | 0 | 2237 | 422 | 5.90 | 0.00 | 0.00 | |
59 | Journal of Immunotherapy | journal | 1.557 Q2 | 106 | 47 | 144 | 1527 | 568 | 144 | 4.21 | 32.49 | 36.39 | |
60 | Endocrine-Related Cancer | journal | 1.545 Q2 | 146 | 102 | 430 | 7826 | 1874 | 391 | 4.22 | 76.73 | 45.73 | |
61 | Cancer journal (Sudbury, Mass.) | journal | 1.491 Q2 | 102 | 69 | 182 | 4022 | 531 | 161 | 3.07 | 58.29 | 46.03 | |
62 | Epigenomics | journal | 1.479 Q2 | 77 | 134 | 367 | 6873 | 1558 | 344 | 3.99 | 51.29 | 47.09 | |
63 | Targeted Oncology | journal | 1.442 Q2 | 59 | 71 | 224 | 2722 | 849 | 218 | 3.93 | 38.34 | 37.45 | |
64 | Sub-Cellular Biochemistry | journal | 1.439 Q2 | 81 | 53 | 171 | 8354 | 566 | 97 | 2.62 | 157.62 | 0.00 | |
65 | Current Problems in Cancer | journal | 1.433 Q2 | 47 | 73 | 117 | 2018 | 410 | 106 | 3.18 | 27.64 | 41.91 | |
66 | Cancer Communications | journal | 1.423 Q2 | 79 | 81 | 225 | 3108 | 855 | 196 | 4.34 | 38.37 | 39.57 | |
67 | Stem Cell Reviews and Reports | journal | 1.408 Q2 | 87 | 70 | 222 | 5445 | 1103 | 203 | 5.08 | 77.79 | 50.68 | |
68 | Clinical Lung Cancer | journal | 1.407 Q2 | 74 | 152 | 443 | 4318 | 1591 | 414 | 3.47 | 28.41 | 37.36 | |
69 | Breast | journal | 1.403 Q2 | 98 | 151 | 566 | 5105 | 1923 | 508 | 3.38 | 33.81 | 52.37 | |
70 | Cancer Prevention Research | journal | 1.371 Q2 | 112 | 93 | 281 | 3492 | 921 | 269 | 2.98 | 37.55 | 46.37 | |
71 | Cancer cytopathology | journal | 1.365 Q2 | 68 | 109 | 387 | 2789 | 1166 | 291 | 2.97 | 25.59 | 47.58 | |
72 | Cell Death Discovery | journal | 1.361 Q2 | 58 | 93 | 311 | 4260 | 1154 | 283 | 3.89 | 45.81 | 43.93 | |
73 | Cancer Research and Treatment | journal | 1.348 Q2 | 58 | 158 | 421 | 3939 | 1464 | 419 | 3.81 | 24.93 | 38.08 | |
74 | Clinical and Experimental Metastasis | journal | 1.340 Q2 | 109 | 45 | 192 | 2379 | 555 | 179 | 2.79 | 52.87 | 37.84 | |
75 | Cancer Causes and Control | journal | 1.332 Q2 | 147 | 136 | 420 | 5984 | 1097 | 407 | 2.42 | 44.00 | 56.96 | |
76 | Cancer Medicine | journal | 1.315 Q2 | 84 | 725 | 1247 | 28849 | 4677 | 1237 | 3.60 | 39.79 | 40.51 | |
77 | Experimental Hematology | journal | 1.302 Q2 | 129 | 86 | 333 | 3774 | 895 | 328 | 2.86 | 43.88 | 41.79 | |
78 | Clinical Cancer Drugs | journal | 1.287 Q2 | 4 | 0 | 1 | 0 | 4 | 1 | 0.00 | 0.00 | 0.00 | |
79 | Breast Cancer: Basic and Clinical Research | journal | 1.282 Q2 | 35 | 23 | 57 | 772 | 168 | 56 | 1.94 | 33.57 | 57.29 | |
80 | Molecular Carcinogenesis | journal | 1.277 Q2 | 107 | 199 | 574 | 9395 | 2195 | 574 | 3.81 | 47.21 | 43.37 | |
81 | Current Opinion in Oncology | journal | 1.275 Q2 | 104 | 88 | 208 | 4322 | 667 | 195 | 3.20 | 49.11 | 46.19 | |
82 | Cellular oncology (Dordrecht) | journal | 1.271 Q2 | 58 | 59 | 155 | 4110 | 749 | 152 | 5.04 | 69.66 | 37.34 | |
83 | Translational Oncology | journal | 1.267 Q2 | 72 | 172 | 355 | 7700 | 1294 | 355 | 3.71 | 44.77 | 40.81 | |
84 | Cancer Chemotherapy and Pharmacology | journal | 1.239 Q2 | 122 | 257 | 766 | 8806 | 2472 | 746 | 3.09 | 34.26 | 36.34 | |
85 | Cytotherapy | journal | 1.233 Q2 | 105 | 108 | 421 | 6036 | 1636 | 379 | 3.64 | 55.89 | 45.51 | |
86 | Cancer genetics | journal | 1.230 Q2 | 52 | 74 | 187 | 2921 | 527 | 175 | 3.09 | 39.47 | 46.06 | |
87 | Journal of Neuro-Oncology | journal | 1.228 Q2 | 135 | 311 | 1042 | 10308 | 3387 | 980 | 3.16 | 33.14 | 34.23 | |
88 | Seminars in Radiation Oncology | journal | 1.202 Q2 | 103 | 42 | 131 | 2656 | 405 | 119 | 3.91 | 63.24 | 37.09 | |
89 | Virus Research | journal | 1.194 Q2 | 144 | 226 | 805 | 11220 | 2484 | 797 | 3.03 | 49.65 | 40.49 | |
90 | BMC Cancer | journal | 1.186 Q2 | 160 | 1247 | 3093 | 46764 | 10616 | 3089 | 3.26 | 37.50 | 40.01 | |
91 | Cancer Epidemiology | journal | 1.168 Q2 | 86 | 172 | 478 | 5924 | 1238 | 450 | 2.24 | 34.44 | 47.90 | |
92 | International Journal of Oncology | journal | 1.159 Q2 | 139 | 287 | 1325 | 15715 | 5252 | 1325 | 3.80 | 54.76 | 38.06 | |
93 | 2016 International Conference on Biometrics, ICB 2016 | conference and proceedings | 1.156 | 18 | 0 | 52 | 0 | 234 | 49 | 0.00 | 0.00 | 0.00 | |
94 | Clinical Breast Cancer | journal | 1.142 Q2 | 80 | 143 | 449 | 4726 | 1186 | 432 | 2.59 | 33.05 | 53.06 | |
95 | Apoptosis : an international journal on programmed cell death | journal | 1.127 Q2 | 128 | 80 | 289 | 3989 | 1207 | 286 | 4.44 | 49.86 | 45.79 | |
96 | Tumor Biology | journal | 1.119 Q2 | 101 | 37 | 2374 | 1537 | 8340 | 2372 | 3.34 | 41.54 | 42.91 | |
97 | Cancer Biology and Therapy | journal | 1.116 Q2 | 130 | 153 | 416 | 6212 | 1445 | 411 | 3.41 | 40.60 | 40.70 | |
98 | Journal of Cancer Research and Clinical Oncology | journal | 1.111 Q2 | 109 | 281 | 747 | 11917 | 2643 | 731 | 3.65 | 42.41 | 39.53 | |
99 | Oncology Research | journal | 1.098 Q2 | 76 | 99 | 410 | 2868 | 1631 | 410 | 4.07 | 28.97 | 37.91 | |
100 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 1.060 Q2 | 90 | 149 | 411 | 4866 | 1091 | 401 | 2.19 | 32.66 | 36.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®